Prestige Consumer Healthcare
PBH
#3940
Rank
ยฃ2.24 B
Marketcap
ยฃ45.62
Share price
1.27%
Change (1 day)
-31.03%
Change (1 year)

Revenue for Prestige Consumer Healthcare (PBH)

Revenue in 2025 (TTM): ยฃ0.84 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's current revenue (TTM ) is ยฃ0.83 Billion. In 2024 the company made a revenue of ยฃ0.89 Billion an increase over the revenue in the year 2023 that were of ยฃ0.89 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prestige Consumer Healthcare from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.84 B-5.01%
2024 ยฃ0.89 B0.09%
2023 ยฃ0.89 B-2.86%
2022 ยฃ0.91 B16.97%
2021 ยฃ0.78 B11.62%
2020 ยฃ0.70 B-3.39%
2019 ยฃ0.72 B-6.9%
2018 ยฃ0.78 B2.82%
2017 ยฃ0.75 B10.29%
2016 ยฃ0.68 B29.36%
2015 ยฃ0.53 B23.85%
2014 ยฃ0.42 B16.39%
2013 ยฃ0.36 B-1.08%
2012 ยฃ0.37 B43.75%
2011 ยฃ0.25 B28.63%
2010 ยฃ0.20 B10.17%
2009 ยฃ0.18 B-16.1%
2008 ยฃ0.21 B33.78%
2007 ยฃ0.16 B-0.3%
2006 ยฃ0.16 B-4.32%
2005 ยฃ0.17 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
GlaxoSmithKline
GSK
ยฃ31.76 B 3,713.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ47.09 B 5,553.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
ยฃ17.60 B 2,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 8,198.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
ยฃ0.45 B-44.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
ยฃ42.28 B 4,976.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
ยฃ63.70 B 7,548.32%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
ยฃ295.59 B 35,387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
ยฃ5.07 B 509.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ32.88 B 3,848.12%๐Ÿ‡บ๐Ÿ‡ธ USA